financetom
Business
financetom
/
Business
/
Eastman Chemical Says Tendered Notes Exceed Cap, Plans Purchase on Pro Rata Basis
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Eastman Chemical Says Tendered Notes Exceed Cap, Plans Purchase on Pro Rata Basis
Aug 12, 2024 9:29 AM

11:57 AM EDT, 08/12/2024 (MT Newswires) -- Eastman Chemical ( EMN ) said Monday it will purchase tendered 3.8% notes due 2025 on a pro rata basis as about $276.9 million of the notes were validly tendered as of Friday, exceeding the $250 million tender cap.

The company said the proration factor in the offer, which will expire at 5 p.m. ET on Aug. 26, is about 90.3%.

Price: 94.52, Change: -0.54, Percent Change: -0.57

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Uber Technologies Safety, Core Services VP to Step Down in Early 2026
Uber Technologies Safety, Core Services VP to Step Down in Early 2026
Mar 10, 2026
10:41 AM EST, 12/18/2025 (MT Newswires) -- Uber Technologies' ( UBER ) senior vice president of safety and core services, Gus Fuldner, is resigning from the company in early 2026, the executive said in a Thursday post on LinkedIn. Fuldner joined the company in 2013, according to Uber's ( UBER ) website. Price: 80.27, Change: +1.13, Percent Change: +1.43 ...
Mar 10, 2026
...
21% PRMB CRASH: Hagens Berman Scrutinizing Primo Brands (PRMB) Over Allegedly Concealed Merger Failure, CEO Replacement, and “Self-Inflicted” Disruptions
21% PRMB CRASH: Hagens Berman Scrutinizing Primo Brands (PRMB) Over Allegedly Concealed Merger Failure, CEO Replacement, and “Self-Inflicted” Disruptions
Mar 10, 2026
SAN FRANCISCO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is alerting investors in Primo Brands Corporation ( PRMB ) that the deadline to move the Court for appointment as lead plaintiff in the pending securities class action lawsuit is January 12, 2026.   The firm urges investors who suffered substantial losses to contact our firm now....
DiaMedica Says FDA Seeks Additional Study Ahead of Pre-IND Submission for Preeclampsia Treatment
DiaMedica Says FDA Seeks Additional Study Ahead of Pre-IND Submission for Preeclampsia Treatment
Mar 10, 2026
10:44 AM EST, 12/18/2025 (MT Newswires) -- DiaMedica Therapeutics ( DMAC ) said Thursday that the US Food and Drug Administration has asked the company to undertake an additional study before submitting an investigational new drug application for its preeclampsia treatment candidate, DM199. Minutes from a pre-investigational new drug meeting with the FDA showed the request for one additional non-clinical,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved